Outbreaks of Human Metapneumovirus in Western Sydney Aged-Care Facilities in 2018
DOI:
https://doi.org/10.33321/cdi.2022.46.54Keywords:
viral respiratory illness, aged care, human metapneumovirusAbstract
Background
Human metapneumovirus (hMPV), first described in 2001, is a cause of acute respiratory tract infection in the elderly, with symptoms ranging from mild to severe, including pneumonia, but outbreaks are rarely described.
Methods
Between 1 July and 31 December 2018, there were three outbreaks of Influenza-like Illness (ILI) where hMPV was the primary pathogen observed, among 64 aged-care facilities (ACFs) in Western Sydney. These outbreaks were investigated by the Western Sydney Local Health District (WSLHD) Public Health Unit (PHU); multiplex polymerase chain reaction (PCR) testing was performed on nasopharyngeal swabs collected by the ACF.
Results
hMPV was the main causative pathogen in three outbreaks (27, 28, and 15 symptomatic cases, respectively) in late winter and early spring. Fifty-five residents and 15 staff cases (70 total cases) were identified; hMPV was detected in 12 of 63 specimens submitted. Of the cases in residents, eight were hospitalised (8/63; 15%), including five with confirmed hMPV and a further one epidemiologically linked to a positive case. Six residents died (6/63; 11%) during the hMPV outbreaks; four of these had laboratory-confirmed hMPV, with a further case epidemiologically linked to a hMPV case, with a primary diagnosis of pneumonia/viral pneumonia. The sixth death was not epidemiologically linked, nor did this case exhibit any respiratory symptoms during the outbreak; however, it was reported in line with public health guidelines.
Conclusion
A major challenge in 2018 was the incompleteness of testing for, and awareness of, hMPV as a viral cause of ILI by facilities, laboratories, and emergency departments, which generally opted for rapid testing for influenza and RSV only. There is no licensed vaccine or approved treatment for hMPV, so efficient infection control measures are most important.
Downloads
References
van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7(6):719–24. doi: https://doi.org/10.1038/89098.
Sastre P, Ruiz T, Schildgen O, Schildgen V, Vela C, Rueda P. Seroprevalence of human respiratory syncytial virus and human metapneumovirus in healthy population analyzed by recombinant fusion protein-based enzyme linked immunosorbent assay. Virol J. 2012;9. doi: https://doi.org/10.1186/1743-422X-9-130.
Ebihara T, Endo R, Kikuta H, Ishiguro N, Yoshioka M, Ma X et al. Seroprevalence of human metapneumovirus in Japan. J Med Virol. 2003;70(2):281–3. doi: https://doi.org/10.1002/jmv.10391.
Peret TCT, Boivin G, Li Y, Couillard M, Humphrey C, Osterhaus ADME et al. Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis. 2002;185(11):1660–3. doi: https://doi.org/10.1086/340518.
Leung J, Esper F, Weibel C, Kahn JS. Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus. J Clin Microbiol. 2005;43(3):1213–9. doi: https:// doi.org/10.1128/JCM.43.3.1213-1219.2005.
Sloots TP, Mackay IM, Bialasiewicz S, Jacob KC, McQueen E, Harnett GB et al. Human metapneumovirus, Australia, 2001–2004. Emerg Infect Dis. 2006;12(8):1263–6. doi: https://doi.org/10.3201/eid1208.051239.
Walsh EE, Peterson DR, Falsey AR. Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med. 2008;168(22):2489–96. doi: https://doi.org/10.1001/archinte.168.22.2489.
Osbourn M, McPhie KA, Ratnamohan VM, Dwyer DE, Durrheim DN. Outbreak of human metapneumovirus infection in a residential aged care facility. Commun Dis Intell Q Rep. 2009;33(1):38–40.
Te Wierik MJ, Nguyen DT, Beersma MF, Thijsen SF, Heemstra KA. An outbreak of severe respiratory tract infection caused by human metapneumovirus in a residential care facility for elderly in Utrecht, the Netherlands, January to March 2010. Euro Surveill. 2012;17(13):20132. doi: https://doi.org/10.2807/ese.17.13.20132-en.
Australian Government Department of Health. Guidelines for the Prevention, Control and Public Health Management of Influenza Outbreaks in Residential Care Facilities in Australia. Canberra: Australian Government Department of Health; 17 July 2017. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cdna-flu-guidelines.htm.
New South Wales Government Department of Health. Influenza Annual Epidemiology Report 2018, NSW. Sydney: New South Wales Government Department of Health; 2019. Available from: https://www.health.nsw.gov.au/Infectious/Influenza/Publications/2018/annual-2018-report.pdf.
Galanti M, Birger R, Ud-Dean M, Filip I, Morita H, Comito D et al. Rates of asymptomatic respiratory virus infection across age groups. Epidemiol Infect. 2019;147. doi: https://doi.org/10.1017/S0950268819000505.
Shaw C, Lee H, Knightly C, Kalidindi S, Zaks T, Smolenov I et al. 2754. Phase 1 trial of an mRNA-based combination vaccine against hMPV and PIV3. Open Forum Infect Dis. 2019;6(Suppl 2):S970. doi: https://doi.org/10.1093/ofid/ofz360.2431.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
